4//SEC Filing
Jones Aranthan II 4
Accession 0001209191-20-046804
CIK 0001347178other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:39 PM ET
Size
5.1 KB
Accession
0001209191-20-046804
Insider Transaction Report
Form 4
Jones Aranthan II
Chief Corp. Affairs Officer
Transactions
- Sale
Common Stock
2020-08-12$11.81/sh−7,200$85,018→ 75,487 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.80 to $11.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001785894
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:39 PM ET
- Size
- 5.1 KB